Andrew G Long Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew G Long.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew G Long. Andrew G Long is EVP, CFO in OWENS & MINOR INC/VA/ ($OMI) and Chief Executive Officer in Insys Therapeutics, Inc. ($INSY) and Chief Financial Officer in Insys Therapeutics, Inc. ($INSY).
Latest Insider Trading Transactions of Andrew G Long
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | OMI | OWENS & MINOR INC/ ... | Long Andrew G | EVP, CFO | Payment of Exercise | F | 33.41 | 4,941 | 165,079 | 116,044 | 121 K to 116 K (-4.08 %) |
Nov 12 2020 | OMI | OWENS & MINOR INC/ ... | Long Andrew G | EVP, CFO | Payment of Exercise | F | 22.17 | 5,118 | 113,466 | 93,158 | 98.3 K to 93.2 K (-5.21 %) |
May 13 2020 | OMI | OWENS & MINOR INC/ ... | Long Andrew G | EVP, CFO | Grant | A | 0.00 | 48,276 | 0 | 98,276 | 50 K to 98.3 K (+96.55 %) |
Nov 12 2019 | OMI | OWENS & MINOR INC/ ... | Long Andrew G | EVP, CFO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Jun 05 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Executive Off ... | Option Exercise | A | 4.30 | 72,674 | 312,498 | 72,674 | |
Jun 05 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Executive Off ... | Grant | A | 0.00 | 12,475 | 0 | 62,075 | 49.6 K to 62.1 K (+25.15 %) |
Apr 23 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 3.81 | 173,000 | 659,130 | 173,000 | |
Apr 23 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 8.06 | 42,400 | 341,744 | 42,400 | |
Apr 23 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Grant | A | 0.00 | 29,000 | 0 | 49,600 | 20.6 K to 49.6 K (+140.78 %) |
Apr 23 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Grant | A | 0.00 | 10,600 | 0 | 20,600 | 10 K to 20.6 K (+106.00 %) |
Apr 19 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 3.81 | 173,000 | 659,130 | 173,000 | |
Apr 19 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 8.06 | 42,400 | 341,744 | 42,400 | |
Apr 19 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Grant | A | 0.00 | 29,000 | 0 | 49,600 | 20.6 K to 49.6 K (+140.78 %) |
Apr 19 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Grant | A | 0.00 | 10,600 | 0 | 20,600 | 10 K to 20.6 K (+106.00 %) |
Apr 19 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 3.81 | 173,000 | 659,130 | 173,000 | |
Apr 19 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 8.06 | 42,400 | 341,744 | 42,400 | |
Apr 19 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Grant | A | 0.00 | 29,000 | 0 | 49,600 | 20.6 K to 49.6 K (+140.78 %) |
Apr 19 2019 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Grant | A | 0.00 | 10,600 | 0 | 20,600 | 10 K to 20.6 K (+106.00 %) |
Aug 07 2018 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | D | 0.00 | 5,000 | 0 | 10,000 | |
Aug 07 2018 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Nov 21 2017 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 5.37 | 15,000 | 80,550 | 15,000 | |
Aug 17 2017 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Aug 17 2017 | INSY | Insys Therapeutics ... | Long Andrew G | Chief Financial Off ... | Option Exercise | A | 9.97 | 100,000 | 997,000 | 100,000 |
Page: 1